An Alternative Approach to Low-Dose Buprenorphine Induction in Pregnancy and Postpartum
Open Access
- 3 October 2024
- journal article
- research article
- Published by Wolters Kluwer Health in O&G Open
- Vol. 1 (4) , 37
Abstract
Low-dose buprenorphine induction, unlike traditional methods, does not require that individuals experience at least moderate withdrawal before initiation. This technique has been widely used and studied in the general population; however, research in pregnancy is limited. We aimed to evaluate obstetric and neonatal outcomes after low-dose buprenorphine induction. In this retrospective case series, we reviewed all cases of low-dose induction during pregnancy or within 6 weeks postpartum at an urban academic medical center over a 3-year period. Nine patients started buprenorphine using this method, and all but one completed induction. There was a high rate of treatment retention and no apparent associated adverse neonatal events. Four individuals are in sustained remission and currently parenting. Though further research is needed, low-dose buprenorphine induction appears effective in the obstetric population.Keywords
This publication has 7 references indexed in Scilit:
- Low-dose buprenorphine initiation during pregnancy: a case reportAJOG Global Reports, 2024
- Low-dose Induction of Buprenorphine in Pregnancy: A Case SeriesJournal of Addiction Medicine, 2023
- ASAM Clinical Considerations: Buprenorphine Treatment of Opioid Use Disorder for Individuals Using High-potency Synthetic OpioidsJournal of Addiction Medicine, 2023
- Successful Buprenorphine/Naloxone Low-dose Induction in Pregnancy: A Case ReportJournal of Addiction Medicine, 2022
- Evidence of Buprenorphine-precipitated Withdrawal in Persons Who Use FentanylJournal of Addiction Medicine, 2021
- Home Induction of Buprenorphine for Treatment of Opioid Use Disorder in PregnancyObstetrics & Gynecology, 2021
- Committee Opinion No. 711: Opioid Use and Opioid Use Disorder in PregnancyObstetrics & Gynecology, 2017